Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats
NG28 Type 2 diabetes in adults: visual summary choosing medicines for first-line and further treatment (PDF)
A randomised controlled trial was conducted in 2022 investigating the impact of semaglutide and liraglutide on weight loss in individuals living with obesity
NamKoong C, Kim MS, Jang B-T, Lee YH, Cho Y-M, Choi HJ
Instead of taking a traditional dose, you take a fraction of that dose
u003ca href=u0022#Safety-Strategy-and-Next-Stepsu0022u003ePeople who should not take a GLP-1u003c/au003e include those with a personal or family history of medullary thyroid carcinoma (MTC), individuals with Multiple Endocrine Neoplasia type 2 (MEN2), and patients with severe gastroparesis or past serious allergic reactions